Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

IGM Biosciences, Inc. Common Stock (IGMS)

Pharmaceutical Preparations

https://www.igmbio.com

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.

325 E MIDDLEFIELD ROAD
MOUNTAIN VIEW, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/18/2019

Market Cap

537,704,786

Shares Outstanding

32,890,000

Weighted SO

58,394,056

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

RNA --.--%

CERE --.--%

CGEM --.--%

MLYS --.--%

GLUE --.--%

DSGN --.--%

HOWL --.--%

IKNA --.--%

STOK --.--%

Beta

0.1860

Last Div

0.0000

Range

3.81-17.7

Chg

-0.1600

Avg Vol

363733

Mkt Cap

537704786

Exch

NASDAQ

Country

US

Phone

650 965 7873

DCF Diff

8.7077

DCF

0.5623

Div Yield

0.0000

P/S

184.7148

EV Multiple

-2.1915

P/FV

4.4995

Div Yield %

0.0000

P/E

-2.4980

PEG

-0.1007

Payout

0.0000

Current Ratio

7.0646

Quick Ratio

7.0646

Cash Ratio

1.7863

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

133.7759

CCC

-133.7759

Gross Margin

-2.0546

Op Margin

-81.4469

Pretax Margin

-75.5479

Net Margin

-75.7135

Eff Tax Rate

0.0099

ROA

-0.6550

ROE

-1.1902

ROCE

-0.7934

NI/EBT

1.0022

EBT/EBIT

0.9276

EBIT/Rev

-81.4469

Debt Ratio

0.1170

D/E

0.3218

LT Debt/Cap

0.2146

Total Debt/Cap

0.2434

Int Coverage

-59.6008

CF/Debt

-4.2649

Equity Multi

2.7501

Rec Turnover

0.0000

Pay Turnover

2.7284

Inv Turnover

0.0000

FA Turnover

0.0422

Asset Turnover

0.0087

OCF/Share

-2.7786

FCF/Share

-2.9147

Cash/Share

4.2471

OCF/Sales

-57.6846

FCF/OCF

1.0490

CF Coverage

-4.2649

ST Coverage

-28.2836

CapEx Coverage

-20.4059

Div&CapEx Cov

-20.4059

P/BV

4.4995

P/B

4.4995

P/S

184.7148

P/E

-2.4980

P/FCF

-3.0526

P/OCF

-3.2787

P/CF

-3.2787

PEG

-0.1007

P/S

184.7148

EV Multiple

-2.1915

P/FV

4.4995

DPS

0.0000

Latest Headlines (EST)

Benzinga Dec 07, 12:00 What To Know About HC Wainwright & Co.'s Downgrade of IGM Biosciences

Revenue Product Segmentation